Keith Michael Gottesdiener
CIK 1615856 · See Remarks · last filed 2025-09-29
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$55.89M
Companies
4
Total Filings
36
Lifetime Open-Market Net
-$2.40M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SEPN | Director | — | $35.95 | — | $0 | 1 | 2025-09-29 |
| PRME | See Remarks | 2,361,078 | $2.77 | $6.55M | $0 | 8 | 2025-05-12 |
| INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Director | 32,830 | $19.00 | $623.8K | $74.9K | 9 | 2023-05-25 |
| RYTM | CEO & President | 558,250 | $88.38 | $49.34M | -$2.48M | 17 | 2020-03-11 |
Recent Filings · Page 2 of 4
36 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2023-04-04 | PRME | Grant (A) | — | $0 | EDGAR |
| 2022-05-27 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +7,737 | $0 | EDGAR |
| 2021-06-01 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +7,029 | $0 | EDGAR |
| 2020-06-01 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +1,595 | $0 | EDGAR |
| 2020-03-11 | RYTM | Exer (M) | +3,408 | $20.9K | EDGAR |
| 2020-02-12 | RYTM | Exer (M) | +6,816 | $41.9K | EDGAR |
| 2020-01-10 | RYTM | Exer (M) | +33,072 | $151.8K | EDGAR |
| 2019-07-17 | RYTM | Exer (M) | +7,500 | $34.4K | EDGAR |
| 2019-06-21 | INTERCEPT PHARMACEUTICALS, INC. (ICPT) Delisted | Grant (A) | +1,570 | $0 | EDGAR |
| 2019-03-19 | RYTM | Sell (S) | −10,290 | -$309.6K | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.